Mar Guasp

Pi, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications

MOGAD-Like Encephalitic Syndromes Without MOG Antibodies in Children.

MOGAD-Like Encephalitic Syndromes Without MOG Antibodies in Children.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: August 24, 2026

Kappa Free Light Chain for Diagnosis and Neurofilament Light Chain for Prognosis in Autoimmune Encephalitis.

Kappa Free Light Chain for Diagnosis and Neurofilament Light Chain for Prognosis in Autoimmune Encephalitis.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: August 03, 2026

Muscle Regeneration Failure May Lead to Clinical Features of Myopathy in Anti-IgLON5 Disease.

Muscle Regeneration Failure May Lead to Clinical Features of Myopathy in Anti-IgLON5 Disease.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: July 13, 2026

Prognostic Determinants of Presentation and Outcome in Anti-IgLON5 Disease.

Prognostic Determinants of Presentation and Outcome in Anti-IgLON5 Disease.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: June 04, 2026

Human IgLON5 Antibodies Reduce Neuronal IgLON5 Clusters and Cause Motor Dysfunction in Mice.

Human IgLON5 Antibodies Reduce Neuronal IgLON5 Clusters and Cause Motor Dysfunction in Mice.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: May 19, 2026

Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective study.

Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective study.

Journal: Therapeutic advances in neurological disorders
Published: January 09, 2026

Clinical Reasoning: A 27-Year-Old Male Patient Presenting With Excessive Daytime Sleepiness of Subacute Onset.

Clinical Reasoning: A 27-Year-Old Male Patient Presenting With Excessive Daytime Sleepiness of Subacute Onset.

Journal: Neurology
Published: December 19, 2025

Relapses, Comorbidities, and Predictors of Outcome in Anti-GABAA Receptor Encephalitis.

Relapses, Comorbidities, and Predictors of Outcome in Anti-GABAA Receptor Encephalitis.

Journal: Annals of neurology
Published: December 18, 2025

Cytokine and Chemokine Profiles in Anti-LGI1 Encephalitis: Markers of Severity and Outcome.

Cytokine and Chemokine Profiles in Anti-LGI1 Encephalitis: Markers of Severity and Outcome.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 20, 2025

Complications, outcomes, and implications of a prolonged vegetative state in anti-NMDA receptor encephalitis: a retrospective international cohort study.

Complications, outcomes, and implications of a prolonged vegetative state in anti-NMDA receptor encephalitis: a retrospective international cohort study.

Journal: The Lancet. Neurology
Published: October 17, 2025

Autoimmune neuropsychiatric disorders manifesting with psychosis.

Autoimmune neuropsychiatric disorders manifesting with psychosis.

Journal: The Journal of clinical investigation
Published: October 15, 2025

CSF-Compartmentalized Antibody Glycoprofiles in NMDAR Encephalitis Associate with Etiology and Functional Recovery.

CSF-Compartmentalized Antibody Glycoprofiles in NMDAR Encephalitis Associate with Etiology and Functional Recovery.

Journal: Annals of neurology
Published: October 06, 2025
Showing 1-12 of 59

Last Updated: 09/26/2026